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Research conducted by the Tobacco Control Research Group at the University of Bath has examined 
the political strategies tobacco companies have developed to gain access to policy élites, exploit the 
political value of the specialised information under their control, and shape public health agendas. 
Tobacco companies constantly innovate in the techniques they use to influence policy that affects how 
their interests and activities are governed. The findings show that seemingly benign initiatives - such 
as Corporate Social Responsibility (CSR) programmes and the European Union (EU) Better Regulation 
agenda - have provided mechanisms for tobacco companies to progress their own interests and 
subvert public health concerns and priorities. As a result, the research stresses the vital importance 
of critically assessing and monitoring how such initiatives are used, in order to ensure balanced and 
effective policymaking. 
www.bath.ac.uk/ipr
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POLICY BRIEF
About this research
Research findings in context: 
case studies of innovative tobacco 
corporation political strategies  
Tobacco companies use various strategies to 
steer political decision-making and shape policy. 
Conventional practices involve lobbying; third party 
techniques, such as the use of Astroturf organisations 
and front groups; and corporate advertising. Innovation 
in political strategy tends to occur when traditional 
political activities lose their effectiveness. In such 
circumstances, companies respond by exploring new 
ways of maintaining their influence in policymaking. 
The Tobacco Control Research Group has produced 
case studies which reveal how tobacco companies 
employ different strategies in various contexts – 
specifically their skilful use of CSR programmes 
and the EU Better Regulation agenda – to achieve 
particular corporate aims. The work has primarily 
focused on the strategies of the British based 
multinational, British American Tobacco (BAT), the 
world’s second largest transnational tobacco company. 
The first case study focuses on how BAT strategically 
used its CSR programme to gain access to the 
UK Department of Health. Based on an analysis of 
internal company documents, this study revealed how 
BAT exploited policymakers’ interest in socially and 
environmentally ethical business practices, to create 
common ground and re-establish meetings between 
the company and the Department. BAT used the 
access they gained through their CSR programme to 
pursue two further objectives. Firstly, to undermine the 
evidence upon which arguments for greater tobacco 
control was based, and secondly, to question the 
qualitatively different approach taken to the tobacco 
industry compared with other ‘controversial’ industries. 
By using CSR to establish itself as a provider of 
reliable information, BAT tried to persuade public 
officials to consider voluntary alternatives to formal 
regulation. In the event, BAT was unsuccessful and the 
Department of Health retained its scepticism of the 
company despite its change of approach. However, 
by showing how BAT actively uses CSR to link the 
company’s preferred policies (e.g. largely ineffective 
alternatives to smoke-free legislation and extensive 
marketing restrictions) to politically salient values, such 
as harm reduction, child health and the importance of 
cooperation between business and government, the 
research highlights the risks that CSR practices pose 
to effective tobacco regulation.  
Key findings
The research found that:
Tobacco companies use Corporate Social 
Responsibility (CSR) Programmes and Better 
Regulation tools politically, to further their 
interests with policymakers and shape 
health policy.
CSR programmes as political strategy 
•	 Tobacco companies have used CSR 
programmes and initiatives to secure 
access to policymakers and frame 
discussions with them; increasing the 
company’s capacity to influence policy 
making.  
•	 They have linked their CSR activities to 
salient social and environmental values 
to strengthen arguments for voluntary 
modes of regulation.  
Better Regulation agendas as political 
strategy 
•	 Tobacco companies have successfully 
changed the underlying framework 
through which all major EU policies are 
assessed, thus helping to formally embed 
tobacco industry participation in EU 
policymaking.  
•	 The purpose behind their efforts to 
integrate stakeholder consultation and 
economic impact assessment procedures 
into EU decision-making was to delay, 
weaken and prevent legislation aimed at 
promoting public health.  
www.bath.ac.uk/ipr
The second case study is concerned with BAT’s 
efforts to shape the policymaking infrastructure 
of the EU. Analysis of internal BAT documents 
and interviews with relevant actors revealed how 
BAT helped to ensure that policymaking tools, 
such as impact assessments (IAs) and mandatory 
stakeholder consultation, associated with the EU’s 
Better Regulation agenda, were formally integrated 
into EU policymaking. To do this BAT established 
a policy network that included a number of major 
corporations (such as Shell, Zeneca, Tesco, 
SmithKline Beecham, Bayer and Unilever), and 
worked with the European Policy Centre, one of the 
largest and most influential think tanks in Europe. 
Their first aim was to ensure that corporations 
would be included in policy discussions in the EU 
and formally consulted early in the policy-making 
process. The success of the strategy has created 
conflicts with Article 5.3 of the World Health 
Organization Framework Convention on Tobacco 
Control, which aims to limit industry access to policy 
making. Their second objective was to shape the 
EU’s impact assessment framework. As a result of 
their efforts changes to the EU Treaty have been 
secured, which specify that policymakers must 
minimise the burdens of legislative developments 
on businesses, and IAs are now required for all 
significant policy proposals by the European 
Commission. The value of impact assessment to 
tobacco companies is that it formalises their capacity 
to oppose and amend health policy proposals, and 
creates opportunities to direct policymakers to 
sources of data which are consistent with  
their interests.  
Policy implications and message 
to policymakers
The research underlines the importance of treating 
corporate managers’ public comments on CSR and 
Better Regulation critically. Specifically, the research 
highlights the need for policymakers to be aware of 
the underlying political motivations (intended aims 
and objectives) for corporate managers’ engagement 
with apparently benign industry initiatives. 
Furthermore, officials need to be alert to the subtle 
ways in which CSR programmes, and industry 
contributions to IAs and stakeholder consultations, 
can subvert public health policy. 
The research further underlines the importance 
of enhancing transparency in governance 
processes, and highlights the importance of strict 
implementation of Article 5.3 of the World Health 
Organization Framework Convention on Tobacco 
Control. The Guidelines for Implementation issued 
pursuant to the Article encourage Parties to 
introduce a range of measures aimed at limiting 
tobacco company access to policymaking, and 
increasing surveillance of tobacco industry efforts 
to exploit their information advantage and influence 
policy. Policymakers in both the UK and EU need to 
consider extending existing requirements aimed at 
improving the transparency of industry-government 
interactions.  
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Methodology
Following a series of litigation cases in the US, 
leading tobacco companies (including BAT) were 
required to make internal documents publicly 
available. These can be reviewed and searched 
at http://legacy.library.ucsf.edu/. For both case 
studies an iterative approach to searching these 
documents was adopted. Initial searches used broad 
terms (such as ‘social reporting’ or ‘CSR’, ‘Better 
Regulation’ or ‘impact assessment’),which were 
then refined by more specific terms. For both cases 
the searches returned a vast number of relevant 
documents - over 700 on each topic - which were 
reviewed and thematically coded by an experienced 
qualitative research team.  Documentary analysis 
was contextualised and enriched by a small number 
of in-depth interviews with relevant individuals in 
the policy fields. 
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